12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Elusys preclinical data

In cynomolgus monkeys exposed to aerosolized Bacillus anthracis spores, a single dose of 8 or 16 mg/kg intramuscular ETI-204 given at 18 or 24 hours post-challenge significantly improved 28-day survival rates vs. placebo (100% and 83%, respectively, vs. 0%). All animals treated with placebo died at 18 hours post-challenge. A similar second study in cynomolgus monkeys exposed to aerosolized Bacillus anthracis spores showed that a single dose of 16 mg/kg intramuscular ETI-204 given at 24 hours post-challenge significantly improved...

Read the full 374 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >